Stocks and Investing Stocks and Investing
Mon, May 11, 2020

Andrew Mok Maintained (AMED) at Hold with Decreased Target to $190 on, May 11th, 2020


Published on 2024-10-27 06:01:01 - WOPRAI, Andrew Mok
  Print publication without navigation


Andrew Mok of UBS, Maintained "Amedisys, Inc." (AMED) at Hold with Decreased Target from $208 to $190 on, May 11th, 2020.

Andrew has made no other calls on AMED in the last 4 months.



There are 3 other peers that have a rating on AMED. Out of the 3 peers that are also analyzing AMED, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $200 on, Friday, February 21st, 2020


These are the ratings of the 2 analyists that currently disagree with Andrew


  • Bill Sutherland of "Benchmark" Upgraded from Hold to Strong Buy and Held Target at $205 on, Monday, March 9th, 2020
  • A.J. Rice of "Credit Suisse" Initiated at Buy and Held Target at $206 on, Friday, January 17th, 2020
Contributing Sources